Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cardio Diagnostics Holdings Inc CDIO

Healthcare Biotechnology
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated... see more

Recent & Breaking News (NDAQ:CDIO)

Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry

Business Wire September 7, 2023

Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital's Heart Attack Prevention Clinic on Coronary Artery Disease Study

Business Wire September 6, 2023

Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences

Business Wire September 5, 2023

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

Business Wire August 18, 2023

Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application

Business Wire August 2, 2023

Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas

Business Wire July 6, 2023

Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD(TM)

Business Wire June 21, 2023

Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease

Business Wire June 13, 2023

Cardio Diagnostics Holding, Inc's Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management

Business Wire May 16, 2023

Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio Diagnostics

Business Wire May 10, 2023

Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360TM BioPharma Research System

Business Wire May 4, 2023

Juniper Research Awards Cardio Diagnostics Holdings, Inc Future Digital Award for Best Digital Diagnostics Solution

Business Wire April 26, 2023

Cardio Diagnostics Holdings, Inc to Attend 22nd Annual AHOU Conference

Business Wire April 12, 2023

Cardio Diagnostics Holdings, Inc Announces Strategic Engagement with Lifespan.io to Drive Longevity & Heart Disease Research and Education

Business Wire April 5, 2023

Cardio Diagnostics Holdings, Inc Sponsors Becker's Hospital Review 13th Annual Meeting

Business Wire March 29, 2023

Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million

Business Wire March 8, 2023

Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy

Business Wire March 8, 2023

Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application

Business Wire March 2, 2023

Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease

Business Wire February 28, 2023

Cardio Diagnostics Holdings Inc to Debut PrecisionCHD(TM) at the American College of Cardiology's 72nd Annual Scientific Session

Business Wire February 22, 2023